Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells

Oncology Reports

Volumn 17, Issue 6, 2007, Pages 1371-1375

  Zhang, Xiaojun ^a   Wei, Haiming ^a   Chen, Qingfeng ^a   Tian, Zhigang ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Chemokine; CX3CR1; Fractalkine; Natural killer cells; Tumor

Indexed keywords

CHEMOKINE (C X3 C MOTIF) LIGAND 1; CHEMOKINE (C-X3-C MOTIF) LIGAND 1; CX3C CHEMOKINE; GAMMA INTERFERON; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CHEMISTRY; CYTOTOXICITY; GENETICS; HELA CELL; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER CELL; NEOPLASM; PHYSIOLOGY;

CELL MEMBRANE; CHEMOKINES, CX3C; CYTOTOXICITY, IMMUNOLOGIC; HELA CELLS; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; NEOPLASMS; RECOMBINANT PROTEINS;

EID: 34548023084     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.6.1371     Document Type: Article

References (30)

1. Trinchieri G: Biology of natural killer cells. Adv Immunol 47: 187-376, 1989.
2. Unanue ER: Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr Opin Immunol 9: 35-43, 1997.
3. Scharton-Kersten TM and Sher A: Role of natural killer cells in innate resistance to protozoan infections. Curr Opin Immunol 9: 44-51, 1997. (Pubitemid 27095896)
4. Scott P and Trinchieri G: The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 7: 34-40, 1995.
5. Hayakawa Y and Smyth MJ: NKG2D and cytotoxic effector function in tumor immune surveillance. Semin Immunol 18: 176-185, 2006. (Pubitemid 43817565)
6. Reyburn H, Mandelboim O, Vales-Gomez M, et al: Human NK cells: their ligands, receptors and functions. Immunol Rev 155: 119-125, 1997. (Pubitemid 27076063)
7. Costello RT, Fauriat C, Sivori S, Marcenaro E and Olive D: NK cells: innate immunity against hematological malignancies? Trends Immunol 25: 328-333, 2004. (Pubitemid 38610357)
8. Rajagopalan S and Long EO: Viral evasion of NK-cell activation. Trends Immunol 26: 403-405, 2005. (Pubitemid 41008075)
9. Kos FJ: Regulation of adaptive immunity by natural killer cells. Immunol Res 17: 303-312, 1998.
10. Le PC, Genin P, Baines MG and Hiscott J: Interferon activation and innate immunity. Rev Immunogenet 2: 374-386, 2000. (Pubitemid 32041163)
11. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A and Lanier LL: NK cell regulation of T cell-mediated responses. Mol Immunol 42: 451-454, 2005. (Pubitemid 39655952)
12. Tsou CL, Haskell CA and Charo IF: Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 276: 44622-44626, 2001.
13. Imai T, Hieshima K, Haskell C, et al : Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530, 1997. (Pubitemid 27508241)
14. Garton KJ, Gough PJ, Blobel CP, et al: Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276: 37993-38001, 2001.
15. Umehara H and Imai T: Role of fractalkine in leukocyte adhesion and migration and in vascular injury. Drug News Perspect 14: 460-464, 2001. (Pubitemid 34130742)
16. Fong AM, Robinson LA, Steeber DA, et al : Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 188: 1413-1419, 1998. (Pubitemid 28489578)
17. Xin H, Kikuchi T, Andarini S, et al: Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. Eur J Immunol 35: 1371-1380, 2005. (Pubitemid 40691418)
18. Zhang X, Wei H, Wang H and Tian Z: Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells. Oncol Rep 15: 485-488, 2006.
19. Ben-Baruch A, Xu L, Young PR, Bengali K, Oppenheim JJ and Wang JM: Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3. J Biol Chem 270: 22123-22128, 1995.
20. Sarin A, Williams MS, Alexander-Miller MA, Berzofsky JA, Zacharchuk CM and Henkart PA: Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 6: 209-215, 1997. (Pubitemid 27145565)
21. Seaman WE: Natural killer cells and natural killer T cells. Arthritis Rheum 43: 1204-1217, 2000.
22. Yoneda O, Imai T, Nishimura M, et al: Membrane-bound form of fractalkine induces IFN-gamma production by NK cells. Eur J Immunol 33: 53-58, 2003. (Pubitemid 36157642)
23. Yoneda O, Imai T, Goda S, et al : Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164: 4055-4062, 2000. (Pubitemid 30215060)
24. Lin SJ, Roberts RL, Ank BJ, Nguyen QH, Thomas EK and Stiehm ER: Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15. Clin Immunol Immunopathol 82: 163-173, 1997. (Pubitemid 27072896)
25. Biron CA, Nguyen KB, Pien GC, Cousens LP and Salazar-Mather TP: Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189-220, 1999. (Pubitemid 29241123)
26. Leibson P: Viewpoint: signal transduction during natural killer cell activation. Nat Immun 14: 117-122, 1995.
27. Lanier LL: Natural killer cell receptor signaling. Curr Opin Immunol 15: 308-314, 2003.
28. Ljunggren HG and Karre K: In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11: 237-244, 1990.
29. Moretta A, Bottino C, Vitale M, et al: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19: 197-223, 2001. (Pubitemid 32368034)
30. Raulet DH, Vance RE and McMahon CW: Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 19: 291-330, 2001. (Pubitemid 32368038)